While some users of marijuana with mental illnesses have said that it helps balance out the brain, some diagnosed individuals with a psychosis identified in a new study should avoid cannabis. A new study coming out of the Columbia University Medical Center has published results showing that for some patients, THC can make the brain hyperactive and allow dopamine to run unregulated in the brain.
The more studies that are done, the better we understand the science of cannabis and it\’s effect on the human brain. Do you think that scientists will figure out exactly which terpenes and cannabinoids may help solve some mental illnesses in the future?
Exposure to THC, the active cannabinoid found in marijuana that has a psychoactive effect, can trigger psychotic episodes especially in people that already have a psychotic disorder or tendencies towards them. THC can make the brain hyperactive and allow dopamine to run unregulated in the brain.
Unchecked dopamine is a signature of schizophrenia and Parkinson’s disease, which would typically be put in check by the production of an acid called GABA. GABA production can be stifled by exposure to THC which is the direct problem for someone that have a psychotic disorder or a tendency towards psychotic episodes in the first place.
Individuals who have had mild or transient psychotic symptoms (such as unusual thoughts, suspiciousness, perceptual disturbances) without using substances such as marijuana or alcohol and have a family history of psychosis or other risk factors are considered at clinical high risk for psychotic disorder. Previous studies have found an association between marijuana use and psychosis in the general population, but none have rigorously examined marijuana’s effects in those at greatest risk for psychosis.
“Many adolescents and young adults who are at high risk for psychosis smoke marijuana regularly or have a cannabis use disorder,” said Margaret Haney, PhD, professor of neurobiology (in Psychiatry) at CUMC and senior author of the paper. “Yet researchers haven’t studied the effects of marijuana in this population in a rigorous, controlled manner.”
In this double-blinded, placebo-controlled laboratory study, the researchers looked at the effects of marijuana in six high-risk young adults and six controls, all experienced and current marijuana smokers who were physically healthy. Participants smoked half of an active or placebo marijuana cigarette, had psychological and physiological assessments before and after smoking, and then repeated this procedure with the opposite (active or placebo) cigarette.
“Although this was a small, preliminary study, it suggests that marijuana may affect individuals at high risk for psychosis differently than other marijuana users, by briefly inducing psychotic-like experiences and impairing their cognition,” said Nehal Vadhan, PhD, a psychologist and associate professor in Psychiatry and Molecular Medicine at Hofstra Northwell School of Medicine and first author of the paper. “While larger studies are needed to confirm these findings, they may aid clinicians in their guidance to individuals at risk for psychosis about marijuana’s potential effects.”
Jeffrey Lieberman,MD, chair of psychiatry at CUMC and and former American Psychiatric Association president, noted that this report “demonstrates the convergent risks of adolescence and expanding cannabis use for the development of psychotic disorders, as well as the opportunity for preventive strategies.”